MYL2 and hematocrit: For example, it is possible that the diagnosis of HCM was in fact delayed in some individuals due to misattribution of their phenotype to HT or obesity at first presentation.12,13 Another possibility is that HT triggers phenotype development in families where the mutation is less penetrant, as suggested previously in one study of a founder mutation in MYL2.